Dataset associated with: "Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation"
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Raw data of western blot in MCD and HFD & fed mice.
应用场景：
创建时间：
2022-10-18
相关数据集
Additional file 4 of Machine learning-based algorithm identifies key mitochondria-related genes in non-alcoholic steatohepatitis
Supplementary Material 4.
NIAID Data Ecosystem60
Administration of glutaredoxin-1 attenuates liver fibrosis caused by aging and non-alcoholic steatohepatitis. Administration of glutaredoxin-1 attenuates liver fibrosis caused by aging and non-alcoholic steatohepatitis
Glutaredoxin-1 (Glrx) controls redox signaling and has an anti-apoptotic function. We evaluated the role of Glrx on hepatic cell damage and fibrosis induced by a high-fat diet. We fed mice a high-fat
NIAID Data Ecosystem30
FLCN Gene Ablation Reduces Fibrosis and Inflammation in a Diet-Induced NASH Model
Non-alcoholic steatohepatitis (NASH) represents a major economic burden and is characterized by triglyceride accumulation, inflammation, and fibrosis. No pharmacological agents are currently approved
NIAID Data Ecosystem30
DataSheet3_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.ZIP
Nonalcoholic fatty liver disease (NAFLD), which is the most common liver disease, is associated with type 2 diabetes mellitus and metabolic syndrome. Although there is no consensus on the treatment of
NIAID Data Ecosystem30
Metabolic modeling of gut microbiota in high-fat diet induced nonalcoholic steatohepatitis through barrier dysfunction and shaping of intrahepatic immunity are ameliorated by VSL#3 supplementation
Metabolic modeling of gut microbiota in high-fat diet-induced nonalcoholic steatohepatitis through barrier dysfunction and shaping of intrahepatic immunity are ameliorated by VSL#3 supplementation
NIAID Data Ecosystem30
